intrauterine injection

PROCEDURE3 trials

Sponsors

Sclnow Biotechnology Co., Ltd.

Conditions

Infertility, FemaleUterus; Injury

Phase 1

hUC Mesenchymal Stem Cells (19#iSCLife®-CSD) Therapy for Patients With Healing Poor After Uterus Injury

CompletedNCT03386708

Sclnow Biotechnology Co., Ltd.Uterus; Injury

Start: 2018-10-01End: 2021-09-21Updated: 2022-02-04

hUC Mesenchymal Stem Cells (19#iSCLife®-UT) Therapy for Patients With Thin Endometrial Infertility

CompletedNCT05495711

Sclnow Biotechnology Co., Ltd.Infertility, Female

Start: 2022-08-01End: 2023-11-01Updated: 2025-05-22

SCLife®-UT hUC-MSCs Advanced Therapy Medicinal Products (hUC-MSCs ATMPs) for Patients With Thin Endometrial Infertility

SuspendedNCT06503471

Sclnow Biotechnology Co., Ltd.Infertility, Female

Start: 2026-12-31End: 2027-12-31Target: 24Updated: 2026-04-23

Related Papers

Intrauterine infusion of clinically graded human umbilical cord-derived mesenchymal stem cells for the treatment of poor healing after uterine injury: a phase I clinical trial

Stem Cell Research & Therapy2022-03-0338 citations